|Articles|March 10, 2022
Survey: Pandemic impact on consumer trust in biopharma
Author(s)Reverba
The biopharma industry launched COVID vaccines and treatments in record time. How did this impact consumer trust? We asked, and compared survey results with 2017 data.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics
2
President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs
3
Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
5